Aeterna Zentaris
AEZS
$1.96
Share price
-1.70%
Change (1 day)
-39.25%
Change (1 year)
Categories
Aeterna Zentaris (AEZS) - Net assets
Net assets on the balance sheet as of September 2023 : $26.27 M
According to Aeterna Zentaris's latest financial reports the company has $26.27 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Aeterna Zentaris - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $35.77 M | -32.48% |
| 2021-12-31 | $52.98 M | 301.07% |
| 2020-12-31 | $13.21 M | -636.38% |
| 2019-12-31 | $-2.47 M | -229.16% |
| 2018-12-31 | $1.9 M | -168.52% |
| 2017-12-31 | $-2.79 M | -144.8% |
| 2016-12-31 | $6.21 M | -71.26% |
| 2015-12-31 | $21.61 M | 49.23% |
| 2014-12-31 | $14.48 M | -15.12% |
| 2013-12-31 | $17.06 M | -354.88% |
| 2012-12-31 | $-6.7 M | 47.27% |
| 2011-12-31 | $-4.55 M | -136.55% |
| 2010-12-31 | $12.43 M | 34.83% |
| 2009-12-31 | $9.22 M | -57.04% |
| 2008-12-31 | $21.47 M | -75.76% |
| 2007-12-31 | $88.59 M | -50.47% |
| 2006-12-31 | $0.17 B | 63.31% |
| 2005-12-31 | $0.10 B | -15.09% |
| 2004-12-31 | $0.12 B | 7.18% |
| 2003-12-31 | $0.12 B | 40.34% |
| 2002-12-31 | $85.75 M | 40.81% |
| 2001-12-31 | $60.9 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $46.75 B | 177,805.47% | 🇨🇭 Switzerland |
 Sanofi SNY | $82.20 B | 312,722.13% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $29.48 B | 112,104.13% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | $26.8 M | 2.01% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | $83.8 M | 218.93% | 🇺🇸 USA |